| Jan 28, 2026 | Other Grant / award | Common Stock | APLS Apellis Pharmaceuticals, Inc. | +55,986 | $0.00 | $0 | 144,517 | low |
| Jan 22, 2026 | Sell | Common Stock | APLS Apellis Pharmaceuticals, Inc. | -7,832 | $21.77 | $170.5K | 88,531 | medium |
| Jan 20, 2026 | Sell | Common Stock | APLS Apellis Pharmaceuticals, Inc. | -2,475 | $19.79 | $49.0K | 96,363 | low |
| Jan 13, 2026 | Sell | Common Stock | APLS Apellis Pharmaceuticals, Inc. | -5,780 | $22.19 | $128.2K | 98,838 | medium |
| Jan 7, 2026 | Other Option exercise | Common Stock | APLS Apellis Pharmaceuticals, Inc. | +888 | $14.95 | $13.3K | 104,618 | low |